Assessing pancreatic fibrosis as a predictor of outcomes
Assessment of Pancreatic Fibrosis as a Prognostic Factor of Its Course
This study is trying to see if the amount of scarring in the pancreas can help predict outcomes for patients having surgery for chronic pancreatitis.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | Moscow Clinical Scientific Center Academic / other |
| Locations | 1 site (Moscow) |
| Trial ID | NCT05775107 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the relationship between the degree of pancreatic fibrosis assessed through histological examination and non-invasive diagnostic methods. It will involve patients aged 18-99 who are scheduled for pancreatic resection and have provided consent to participate. The study will collect various demographic, anthropometric, and medical history data to analyze the correlation between fibrosis severity and diagnostic techniques. The goal is to develop reliable non-invasive methods for evaluating pancreatic fibrosis in patients with chronic pancreatitis.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-99 who are scheduled for pancreatic resection and can provide informed consent.
Not a fit: Patients who are unable to provide informed consent or cannot have their clinical data collected will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to non-invasive diagnostic techniques that improve the management of pancreatic fibrosis in patients with chronic pancreatitis.
How similar studies have performed: While the approach of using non-invasive techniques for assessing pancreatic fibrosis is promising, it is still largely untested in this specific context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age 18-99 years * pre-planned pancreatic resection * consent of the patient to participate in the study Exclusion Criteria: * inability to sign informed voluntary consent at the time of an inclusion to the study * the impossibility of obtaining clinical data, data of instrumental, laboratory studies, and histological examination of the material obtained during surgical treatment.
Where this trial is running
Moscow
- A.S. Loginov Moscow Clinical Scientific Center — Moscow, Russian Federation (Recruiting)
Study contacts
- Principal investigator: Dmitry S. Bordin, MD PhD — A.S. Loginov Moscow Clinical Research Center
- Study coordinator: Dmitry Bordin
- Email: d.bordin@mknc.ru
- Phone: +79262311603
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.